Skip to main content
Erschienen in: Digestive Diseases and Sciences 10/2012

01.10.2012 | Original Article

Higher Prevalence of Obesity in Gastric Cardia Adenocarcinoma Compared to Gastric Non-Cardia Adenocarcinoma

verfasst von: Yuri Cho, Dong Ho Lee, Hong Sang Oh, Ji Yeon Seo, Dong Hyeon Lee, Nayoung Kim, Sook Hyang Jeong, Jin Wook Kim, Jin Hyuk Hwang, Young Soo Park, Sang Hyub Lee, Cheol Min Shin, Hyun Jin Jo, Hyun Chae Jung, Yong Bum Yoon, In Sung Song

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

Background and Aims

Obesity is one of the main risk factors for gastric cardia adenocarcinoma (GCA) in the West. Also, recent studies have suggested that GCA is distinct from distal stomach tumor, with differing risk factors, tumor characteristics, and biological behavior. The objective of our research was to evaluate the relationship between obesity and GCA compared to non-cardia adenocarcinoma.

Materials and Methods

A total of 298 patients who were diagnosed with gastric adenocarcinoma and underwent surgery at Seoul National University Bundang Hospital were evaluated. Ninety-one cases were GCA, and 207 cases were non-cardiac adenocarcinoma. Obesity was estimated by body mass index (BMI, kg/m2). The degree of obesity was determined by using BMI <18.5, 18.5–23.9, 24–27.9, and ≥28 (kg/m2) as the cut-off points for underweight, normal weight, overweight, and obese, respectively. Association with obesity was estimated by odds ratio (OR) and 95% confidence interval (CI).

Results

Obesity was more prevalent in patients with GCA at the time of diagnosis for gastric cancer. Among obese persons with a BMI of 28 kg/m2 or higher, the OR was 3.937 (95% CI, 1.492–10.389; p = 0.006) for GCA compared to non-cardia adenocarcinoma. For overweight individuals, the OR was 2.194 (95% CI, 1.118–4.305; p = 0.022). Multivariate analysis of age, Helicobacter pylori infection, smoking, stage, and BMI with logistic regression was performed. BMI was an independent risk factor for GCA (OR, 1.123; 95% CI, 1.037–1.217; p = 0.004).

Conclusion

Obesity was more prevalent in patients with GCA compared to that in patients with gastric non-cardia adenocarcinoma. Also, BMI was an independent risk factor for GCA.
Literatur
1.
Zurück zum Zitat Vial M, Grande L, Pera M. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res. 2010;182:1–17.PubMedCrossRef Vial M, Grande L, Pera M. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res. 2010;182:1–17.PubMedCrossRef
2.
Zurück zum Zitat Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–831.PubMedCrossRef Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–831.PubMedCrossRef
3.
Zurück zum Zitat Terry P, Lagergren J, Wolk A, Nyren O. Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer. 2000;38:186–191.PubMedCrossRef Terry P, Lagergren J, Wolk A, Nyren O. Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer. 2000;38:186–191.PubMedCrossRef
4.
Zurück zum Zitat Oberg S, DeMeester TR, Peters JH, et al. The extent of Barrett’s esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg. 1999;117:572–580.PubMedCrossRef Oberg S, DeMeester TR, Peters JH, et al. The extent of Barrett’s esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg. 1999;117:572–580.PubMedCrossRef
5.
Zurück zum Zitat Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90:150–155.PubMedCrossRef Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90:150–155.PubMedCrossRef
6.
Zurück zum Zitat Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1995;4:85–92.PubMed Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1995;4:85–92.PubMed
7.
Zurück zum Zitat Deans C, Yeo MS, Soe MY, Shabbir A, Ti TK, So JB. Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. World J Surg. 2011;35:617–624.PubMedCrossRef Deans C, Yeo MS, Soe MY, Shabbir A, Ti TK, So JB. Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. World J Surg. 2011;35:617–624.PubMedCrossRef
8.
Zurück zum Zitat Peleteiro B, Cavaleiro-Pinto M, Barros R, Barros H, Lunet N. Is cardia cancer aetiologically different from distal stomach cancer? Eur J Cancer Prev. 2011;20:96–101.PubMedCrossRef Peleteiro B, Cavaleiro-Pinto M, Barros R, Barros H, Lunet N. Is cardia cancer aetiologically different from distal stomach cancer? Eur J Cancer Prev. 2011;20:96–101.PubMedCrossRef
9.
Zurück zum Zitat Xue L, Zhang X, Li Y, et al. Differences of immunophenotypic markers and signaling molecules between adenocarcinomas of gastric cardia and distal stomach. Hum Pathol. 2011;42:594–601.PubMedCrossRef Xue L, Zhang X, Li Y, et al. Differences of immunophenotypic markers and signaling molecules between adenocarcinomas of gastric cardia and distal stomach. Hum Pathol. 2011;42:594–601.PubMedCrossRef
10.
Zurück zum Zitat Lehmann K, Schneider PM. Differences in the molecular biology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le Cancer. 2010;182:65–72.PubMedCrossRef Lehmann K, Schneider PM. Differences in the molecular biology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le Cancer. 2010;182:65–72.PubMedCrossRef
11.
Zurück zum Zitat Peters CJ, Hardwick RH, Vowler SL, Fitzgerald RC. Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma. Br J Surg. 2009;96:724–733.PubMedCrossRef Peters CJ, Hardwick RH, Vowler SL, Fitzgerald RC. Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma. Br J Surg. 2009;96:724–733.PubMedCrossRef
12.
Zurück zum Zitat Maeda H, Okabayashi T, Nishimori I, et al. Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach? J Am Coll Surg. 2008;206:306–310.PubMedCrossRef Maeda H, Okabayashi T, Nishimori I, et al. Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach? J Am Coll Surg. 2008;206:306–310.PubMedCrossRef
13.
Zurück zum Zitat Dawsey SM, Mark SD, Taylor PR, Limburg PJ. Gastric cancer and H. pylori. Gut. 2002;51:457–458.PubMedCrossRef Dawsey SM, Mark SD, Taylor PR, Limburg PJ. Gastric cancer and H. pylori. Gut. 2002;51:457–458.PubMedCrossRef
14.
Zurück zum Zitat Enroth H, Kraaz W, Rohan T, Nyren O, Engstrand L. Does the method of Helicobacter pylori detection influence the association with gastric cancer risk? Scand J Gastroenterol. 2002;37:884–890.PubMedCrossRef Enroth H, Kraaz W, Rohan T, Nyren O, Engstrand L. Does the method of Helicobacter pylori detection influence the association with gastric cancer risk? Scand J Gastroenterol. 2002;37:884–890.PubMedCrossRef
15.
Zurück zum Zitat Shin A, Shin HR, Kang D, Park SK, Kim CS, Yoo KY. A nested case-control study of the association of Helicobacter pylori infection with gastric adenocarcinoma in Korea. Br J Cancer. 2005;92:1273–1275.PubMedCrossRef Shin A, Shin HR, Kang D, Park SK, Kim CS, Yoo KY. A nested case-control study of the association of Helicobacter pylori infection with gastric adenocarcinoma in Korea. Br J Cancer. 2005;92:1273–1275.PubMedCrossRef
16.
Zurück zum Zitat Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15:83–96.PubMed Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15:83–96.PubMed
17.
Zurück zum Zitat Zhou BF. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases–report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002;15:245–252.PubMed Zhou BF. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases–report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002;15:245–252.PubMed
18.
Zurück zum Zitat Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF Jr, Leitzmann M, Schatzkin A. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer. 2008;44:465–471.PubMedCrossRef Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF Jr, Leitzmann M, Schatzkin A. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer. 2008;44:465–471.PubMedCrossRef
19.
Zurück zum Zitat Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:872–878.PubMedCrossRef Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:872–878.PubMedCrossRef
20.
Zurück zum Zitat Ryan AM, Rowley SP, Fitzgerald AP, Ravi N, Reynolds JV. Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity. Eur J Cancer. 2006;42:1151–1158.PubMedCrossRef Ryan AM, Rowley SP, Fitzgerald AP, Ravi N, Reynolds JV. Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity. Eur J Cancer. 2006;42:1151–1158.PubMedCrossRef
21.
Zurück zum Zitat Mattioli S, Ruffato A, Di Simone MP, et al. Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors. Ann Thorac Surg. 2007;83:1814–1819.PubMedCrossRef Mattioli S, Ruffato A, Di Simone MP, et al. Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors. Ann Thorac Surg. 2007;83:1814–1819.PubMedCrossRef
22.
Zurück zum Zitat Qiu HB, Zhang LY, Keshari RP, et al. Relationship between H. Pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer. 2010;10:374.PubMedCrossRef Qiu HB, Zhang LY, Keshari RP, et al. Relationship between H. Pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer. 2010;10:374.PubMedCrossRef
23.
Zurück zum Zitat Ramos CM, Boleo-Tome C, Monteiro-Grillo I, Camilo M, Ravasco P. The diversity of nutritional status in cancer: new insights. Oncologist. 2010;15:523–530.CrossRef Ramos CM, Boleo-Tome C, Monteiro-Grillo I, Camilo M, Ravasco P. The diversity of nutritional status in cancer: new insights. Oncologist. 2010;15:523–530.CrossRef
Metadaten
Titel
Higher Prevalence of Obesity in Gastric Cardia Adenocarcinoma Compared to Gastric Non-Cardia Adenocarcinoma
verfasst von
Yuri Cho
Dong Ho Lee
Hong Sang Oh
Ji Yeon Seo
Dong Hyeon Lee
Nayoung Kim
Sook Hyang Jeong
Jin Wook Kim
Jin Hyuk Hwang
Young Soo Park
Sang Hyub Lee
Cheol Min Shin
Hyun Jin Jo
Hyun Chae Jung
Yong Bum Yoon
In Sung Song
Publikationsdatum
01.10.2012
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2012
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2095-6

Weitere Artikel der Ausgabe 10/2012

Digestive Diseases and Sciences 10/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.